Document:

Exhibit
10.2

 

STOCK
PURCHASE AGREEMENT

THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY
STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE UPON EXEMPTION(S) FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS

 

STOCK
PURCHASE AGREEMENT (this “Agreement”) made as of the last date set forth on the signature page hereof between FOMO
CORP. (“FOMO” or the “Company”) and the undersigned (the “Investor”).

 

W
I T N E S S E T H:

 

WHEREAS,
the Company has agreed to sell to Investor and Investor has agreed to purchase from Company, certain shares of Company’s
Series A Preferred Stock of FOMO CORP., a California Corporation (hereinafter referred to as the, “Company”) (the
“Preferred Stock”) for a price of $0.10 for each Series A preferred share (the “Purchase Price”); and

 

WHEREAS,
in return for an Investment under the terms of this Agreement in the amount of $_____________, FOMO shall sell to Investor a total
of $_____________ worth of Company’s Preferred Stock (the Investment Amount) at the Purchase Price, constituting participation
in part or in the whole in a Series A investment round that shall total up yo $250,000.00;

 

WHEREAS
the Shares of Series A Preferred Stock are being sold to the Investor at $0.10 per share, which represents a share price in the
Common Stock of $0.002;

 

WHEREAS
the Investor understands and acknowledges that Series A Preferred Stock is convertible into Common Stock on a 50 for 1 basis and
votes on a 50 for 1 basis (subject to adjustment for stock and splits, reorganizations, etc.) as provided for in the Company’s
articles of incorporation; and,

 

NOW,
THEREFORE, in consideration of the mutual representations and covenants hereinafter set forth, the parties hereto do hereby agree
as follows:

 

I.
CLOSING

 

1.1
Upon execution of this Agreement, Investor shall deliver via wire transfer, immediately available funds equal to the entire Investment
within 72 hours of the business day when all of the documents have been executed and delivered by the applicable parties thereto,
and all conditions precedent to (i) the Investors’ obligations to pay the Principle Amount and (ii) the Company’s
obligations to deliver the securities have been satisfied or waived (the, “Closing”) the date of the Closing is the
“Closing Date”.

 

    	1

    	 

    

 

Upon
the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement
by the parties hereto, the Company agrees to sell, and the Investor agrees to purchase, the total investment amount in principal
amount of the Preferred Series A Stock. The Company and each Investor shall deliver the other items set forth in Section 1
..3 deliverable at the Closing. Upon satisfaction of the conditions set forth in Section 1.2 and Section 1.3,
the Closing shall occur at such other location as the parties shall mutually agree. The Investor may conduct multiple closings
for the sale of the Preferred Stock by submitting EXHIBIT A: INVESTMENT SUBMISSION with the appropriate funds, until investor
has invested an aggregate principal amount of the Total Investment Amount in cash consideration. The First Closing Date shall
be no sooner than the opening of business on March 31, 2021.

 

1.2
Deliveries.

 

(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to Investor the following:

 

(i)
this Agreement executed by the Company;

 

(ii)
a certificate or book entry confirmation with a principal amount equal to the Investor’s Principal Amount, registered in
the name of such Investor;

 

(b)
On the Closing Date, Investor shall deliver or cause to be delivered to the Company the following:

 

(i)
this Agreement executed by Investor; and

 

(ii)
such Investor’s Principle Amount by wire transfer.

 

1.3
Closing Conditions.

 

(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)
the accuracy in all material respects on the Closing Date of the representations and warranties of the Investors contained herein;

 

(ii)
all obligations, covenants and agreements of Investor required to be performed at or prior to the Closing Date shall have been
performed; and

 

(iii)
the delivery by Investor of the items set forth in Section 2.2(b) of this Agreement.

 

(b)
The respective obligations of the Investors hereunder in connection with the Closing are subject to the following conditions being
met:

 

(i)
the accuracy in all material respects when made and on the Closing Date of the representations and warranties of the Company contained
herein;

 

(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been
performed;

 

(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

II.
WARRANTS AND REPRESENTATIONS BY INVESTOR

 

2.1
Subject to the terms and conditions hereinafter set forth, the Investor hereby irrevocably agrees to purchase from the Company
the Series A Preferred Stock for the aggregate amount indicated on the signature page of this Agreement (the “Principal
Amount”). The Principal Amount is payable by wire transfer by the Investor to the Escrow Agent as described in that certain
Escrow Agreement dated of even date herewith.

 

    	2

    	 

    

 

2.2
The Investor recognizes that the purchase of the Series A Preferred Stock involves a high degree of risk and that the Investor
is able to bear the economic risk of an investment in the Preferred Stock. The Investor has knowledge and experience in business
and financial matters such that the Investor is a sophisticated investor capable of evaluating the merits and risks of the prospective
investment.

 

2.3
The Investor is an “accredited investor” as such term is defined in Rule 501 of Regulation D (“Regulation D”)
promulgated under the Securities Act, as indicated by the Investor’s Confidential Investor Questionnaire attached hereto.
Company may rely on the accuracy of the Investor’s representations therein.

 

2.4
The Investor hereby acknowledges that the Offering has not been registered or otherwise reviewed by the United States Securities
and Exchange Commission (the “SEC”) nor any state regulatory authority. The Offering is exempt from the registration
requirements of Section 5 of the Securities Act, under 4(1) of the Securities Act and Rule 506 of Regulation D. The Investor understands
that the Preferred Stock has not yet been transferred to common stock and has not been registered under the Securities Act or
under any state securities or “blue sky” laws and agrees not to sell, pledge, assign or otherwise transfer or dispose
of the shares of Preferred Stock unless they are converted to common stock and they are registered under applicable law or exempted
from registration.

 

2.5
The Investor, if an entity, represents that it was not formed for the purpose of purchasing the Preferred Stock.

 

2.6
The Investor consents to the placement of a legend on any certificate or other document evidencing the Preferred Stock or upon
conversion the common stock that such shares of Preferred Stock or upon conversion the common stock have not been registered under
the Securities Act or any state securities or “blue sky” laws and setting forth or referring to the restrictions on
transferability and sale thereof contained in this Agreement or by law. The Investor is aware that the Company will make a notation
in its appropriate records with respect to the restrictions on the transferability of such Preferred Stock or upon conversion
the common stock. In addition to any legend pursuant to Article III, the legend to be placed on each certificate of Preferred
Stock or upon conversion the common stock shall be in form substantially similar to the following:

 

“The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended and may not be
sold, transferred, pledged, hypothecated or otherwise disposed of in the absence of (i) an effective registration statement for
such securities under said act or (ii) an opinion of Company counsel that such registration is not required.”

 

2.7
The Investor hereby represents that the address of the Investor furnished by Investor on the signature page hereof is the Investor’s
principal residence if Investor is an individual or its principal business address if it is a corporation or other entity.

 

2.8
The Investor represents that the Investor has full power and authority (corporate, statutory and otherwise) to execute and deliver
this Agreement and to purchase the Preferred Stock. This Agreement constitutes the legal, valid and binding obligation of the
Investor, enforceable against the Investor in accordance with its terms.

 

    	3

    	 

    

 

2.9
If the Investor is a corporation, partnership, limited liability Company, trust, employee benefit plan, individual retirement
account, Keogh Plan, or other tax-exempt entity, it is authorized and qualified to invest in the Company and the person signing
this Agreement on behalf of such entity has been duly authorized by such entity to do so.

 

2.10
The Investor acknowledges that if he or she is a Registered Representative of a FINRA member firm, he or she must give such firm
the notice required by the FINRA’s Rules of Fair Practice.

 

2.11
The Investor agrees not to issue any public statement with respect to the Investor’s investment or proposed investment in
the Company or the terms of any agreement or covenant between them and the Company without the Company’s prior written consent,
except such disclosures as may be required under applicable law or under any applicable order, rule or regulation.

 

2.12
The Investor agrees to hold the Company and its directors, officers, employees, affiliates, controlling persons and agents and
their respective heirs, representatives, successors and assigns harmless and to indemnify them against all liabilities, costs
and expenses incurred by them as a result of (a) any sale or distribution of the Preferred Stock or upon conversion the common
stock by the Investor in violation of the Securities Act or any applicable state securities or “blue sky” laws; or
(b) any false representation or warranty or any breach or failure by the Investor to comply with any covenant made by the Investor
in this Agreement (including the Confidential Investor Questionnaire contained in Article V herein) or any other document furnished
by the Investor to any of the foregoing in connection with this transaction.

 

III.
WARRANTS AND REPRESENTATIONS BY COMPANY

 

3.1
Company hereby warrants and represents to the Investor, that the statements below are all true and complete as of the date of
Closing:

 

(a)
Company represent that it has full power and authority to sell, transfer and deliver the Preferred Stock in accordance with the
terms of this Agreement, and otherwise to consummate and close the transaction provided for in this Agreement in the manner and
upon the terms herein specified.

 

(b)
Company warrants that the Preferred Stock being sold by the Company have been validly issued, fully paid, and are non-assessable.

 

(c)
Company warrants that the Preferred Stock being sold by the Company is a valid Preferred Stock of the Company convertible into
Common Stock of the Company on a 50 for 1 basis and votes on a 50 for 1 basis.

 

(d)
Company warrants that, other than a 50% interest in Kanab Corp., which is an Internet social site targeting the cannabis market,
210 million common shares of Mobicard Inc. (OTC: PTOP), a mobile business applications provider, Purge Virus LLC a disinfection
technology provider, and publicly announced letters of intent to purchase/explore purchase of Independence LED Lighting LLC, EcoLite
Holdings, LCC and PPE Source International, LLC, it does not have any subsidiaries and at closing will not, directly or indirectly,
own any interest in or control any corporation, partnership, joint venture, or other business entity.

 

    	4

    	 

    

 

(e)
Company warrants that the execution, acknowledgement, sealing, delivery, and performance of this Agreement by the Company and
the consummation of the transactions contemplated by this Agreement will not:

 

(i)
violate or require any registration, qualification, consent, approval, declaration, reporting or filing under (i) any law, statue,
ordinance, rule or regulation (hereinafter collectively referred to as “Laws”) of any federal, state or local government
or governmental agency (“Governmental Entities”), (ii) any judgment, injunction order, writ or decree of any court,
arbitrator, or Governmental Entities applicable to the Company or any of its assets or properties; or

 

(ii)
conflict with, require any consent, approval, authorization or filing under, result in the breach or termination of any provision
of, constitute a default under, result in the acceleration of the performance of Company’s obligations under, or result
in the creation of any claim, security interest, lien charge, or encumbrance upon any of Investor’s or Company’s properties,
assets, or businesses pursuant to (i) Company’s Articles or By-Laws, or (ii) any indenture, mortgage, deed of trust, license,
permit, approval, consent, franchise, lease, contract, or other instrument or agreement to which Investor or Company is a party
or by which Company or any of Company’s assets or properties is bound.

 

(f)
Company warrants that it is not currently conducting any business that is not in compliance with all Laws and nor is Company in
(i) violation of any Laws of any Governmental Entities, or (ii) violation of any restrictive or similar covenant, agreement, commitment,
understanding or arrangement.

 

(g)
Company warrants that there is not and it is not aware of any action, suit, proceeding, claim, arbitration, or investigation by
any Governmental Entities or other person (i) to which Company is or may be a party relating to the activities of the Company
prior to the date of Closing, (ii) threatened against or relating to Company or any of Company’s assets or businesses, (iii)
challenging Company’s right to execute, acknowledge, seal, deliver, perform under or consummate the transactions contemplated
by this Agreement, or (iv) asserting any rights with respect to any of the Preferred Stock, and there is no basis for any such
action, suit, proceeding, claim, arbitration or investigation.

 

(h)
Company warrants that at Closing its primary assets include the software code, trademarks, intellectual property, and computer
equipment that comprise the Kanab Club social network, 233 million common shares of Mobicard Inc. (OTC: PTOP) and Purge Virus
LLC.

 

(i)
Company warrants that at Closing it will have no outstanding leases or will be subject to any other Agreement.

 

(j)
Company warrants that at Closing it will have no outstanding employment obligation of any kind that is in default and/or in dispute.

 

    	5

    	 

    

 

(l)
Company warrants that at Closing, Investor shall have no obligations whatsoever, for any compensation or other amounts payable
to any employee, director, consultant or independent contractor of Company, excluding industry standard bonus, salary, compensation,
accrued vacation, fringe, pension or profit sharing benefits, or severance paid or payable to any employee, director, consultant
or independent contractor of Company relating to service with or for the Company at any time prior to the Closing Date.

 

(m)
Company warrants that it has disclosed to Investor in this Agreement all material facts related to the transactions contemplated
by this Agreement. No representation or warranty of the Company contained in this Agreement or other agreements and instrument
referred to in this Agreement, and no statement contained in any certificate, schedule, list or other writing furnished to Investor
pursuant to the provisions of this Agreement contains any untrue statement of a material fact, or omits to state a material fact
necessary in order to make the statements herein or therein not misleading.

 

IV.
NOTICES

 

4.1
Any notice or other communication given hereunder shall be deemed sufficient if in writing and sent by registered or certified
mail, return receipt requested, or delivered by hand against written receipt therefor, addressed as follows:

 

if
to the Company, to FOMO at:

 

FOMO
CORP. 

1
E. Erie St. Ste 525 #2250

Chicago,
IL

info@fomoworldwide.com

 

if
to the Investor, to the Investor’s address indicated on the signature page of this Agreement.

 

Notices
shall be deemed to have been given or delivered on the date of mailing, except notices of change of address, which shall be deemed
to have been given or delivered when received.

 

All
wire transfers should be sent to the following at:

 

FOMO
CORP. p/k/a 2050 Motors, Inc.

2810
Bristol Dr. 309

Lisle,
IL 60532

 

Bank
of America

802
Commons Dr.

Geneva,
IL 60134

ABA
#026009593

A/C
#291028003885

 

    	6

    	 

    

 

V.
MISCELLANEOUS

 

5.1
Except as otherwise provided herein, this Agreement shall not be changed, modified or amended except by a writing signed by the
parties to be charged, and this Agreement may not be discharged except by performance in accordance with its terms or by a writing
signed by the party to be charged.

 

5.2
This Agreement shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives,
successors and assigns. This Agreement sets forth the entire agreement and understanding between the parties as to the subject
matter hereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them.

 

5.3
NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT
ALL THE TERMS AND PROVISIONS HEREOF SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF CALIFORNIA
WITHOUT REGARD TO SUCH STATE’S PRINCIPLES OF CONFLICTS OF LAW. IN THE EVENT THAT A JUDICIAL PROCEEDING IS NECESSARY, THE
SOLE FORUM FOR RESOLVING DISPUTES ARISING OUT OF OR RELATING TO THIS AGREEMENT IS THE STATE AND FEDERAL COURTS SITTING IN DUPAGE
COUNTY OF ILLINOIS AND THE PARTIES HEREBY IRREVOCABLY CONSENT TO THE JURISDICTION OF SUCH COURTS AND AGREE TO SAID VENUE.

 

5.4
In order to discourage frivolous claims the parties agree that unless a claimant in any proceeding arising out of this Agreement
succeeds in establishing his claim and recovering a judgment against another party (regardless of whether such claimant succeeds
against one of the other parties to the action), then the other party shall be entitled to recover from such claimant all of its/their
reasonable legal costs and expenses relating to such proceeding and/or incurred in preparation therefor.

 

5.5
The holding of any provision of this Agreement to be invalid or unenforceable by a court of competent jurisdiction shall not affect
any other provision of this Agreement, which shall remain in full force and effect. If any provision of this Agreement shall be
declared by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced in whole or in part, such
provision shall be interpreted so as to remain enforceable to the maximum extent permissible consistent with applicable law and
the remaining conditions and provisions or portions thereof shall nevertheless remain in full force and effect and enforceable
to the extent they are valid, legal and enforceable, and no provisions shall be deemed dependent upon any other covenant or provision
unless so expressed herein.

 

5.6
It is agreed that a waiver by either party of a breach of any provision of this Agreement shall not operate, or be construed,
as a waiver of any subsequent breach by that same party.

 

5.7
The parties agree to execute and deliver all such further documents, agreements and instruments and take such other and further
action as may be necessary or appropriate to carry out the purposes and intent of this Agreement.

 

5.8
This Agreement may be executed in two or more counterparts each of which shall be deemed an original, but all of which shall together
constitute one and the same instrument.

 

5.9
Nothing in this Agreement shall create or be deemed to create any rights in any person or entity not a party to this Agreement.

 

    	7

    	 

    

 

**
SIGNATURES FOLLOW **

 

The
Investor has set their hand on the date above.

 

_______________________________________

 

INVESTOR

 

ACKNOWLEDGEMENT
OF SUBMISSION OF PRINCIPLE AMOUNT BY FOMO

 

This
Stock Purchase Agreement is agreed to and accepted as of ________________, 2021.

 

________________________________

Vikram
Grover

CEO

 

    	8

    	 

    

 

EXHIBIT
A – INVESTMENT SUBMISSION

 

Subsequent
investment under this INVESTMENT SUBMISSION constitutes a reaffirmation of the Investment Agreement and is made under the terms
of that Agreement. 

 

PRINCIPAL
AMOUNT = $____________

 

Dated:
____________

 

	 	 	 
	Signature	 	Signature
    (if purchasing jointly)
	 	 	 
	 	 	 
	Name
    Typed or Printed	 	Name
    Typed or Printed
	 	 	 
	 	 	 
	Title
    (if Investor is an Entity)	 	Title
    (if Investor is an Entity)
	 	 	 
	 	 	 
	Entity
    Name (if applicable)	 	Entity
    Name (if applicable)
	 	 	 
	 	 	 
	Address	 	Address
	 	 	 
	 	 	 
	City,
    State and Zip Code	 	City,
    State and Zip Code
	 	 	 
	 	 	 
	Telephone	 	Telephone
	 	 	 
	 	 	 
	Facsimile	 	Facsimile
	 	 	 
	 	 	 
	E-Mail	 	E-Mail
	 	 	 
	 	 	 
	Tax
    ID # or Social Security #	 	Tax
    ID # or Social Security # 
	 	 	 
	Name
    in which securities should be issued:	 	 

 

    	9

    	 

    

 

Manner
in which title is to be held: (check only one)

 

[  ]
Individual Ownership

 

	Joint
    Purchase:	Entity
	[  ]
        Community Property

        [  ]
        Joint Tenant with Right of Survivorship

        (JTWRS)

        

        [  ]
        Tenants in Common (TIC)

        [  ]
        Tenants by Entirety (TBE)

        (If
Securities are being purchased for as a joint purchase, both parties must sign.)
	[  ] Partnership

                                                         [  ]
        Company

        [  ]
        Self-Directed Retirement Account

        [  ]
        Trust

        [  ]
        Other_________________________

        (Entities
        must complete Cert. of Signatory – p. 12

        

 

CONFIDENTIAL
INVESTOR QUESTIONNAIRE

 

The
Investor represents and warrants that he, she or it comes within one category marked below, and that for any category marked,
he, she or it has truthfully set forth, where applicable, the factual basis or reason the Investor comes within that category.
ALL INFORMATION IN RESPONSE TO THIS SECTION WILL BE KEPT STRICTLY CONFIDENTIAL. The undersigned agrees to furnish any additional
information which the Company deems necessary in order to verify the answers set forth below.

 

	Category
    A ___	The
    Investor is (a) an individual (not a partnership, corporation, etc.) whose individual net worth, or joint net worth with his
    or her spouse, presently exceeds $1,000,000, or (b) a self-directed retirement account (“Retirement Account”)
    whose participant’s net worth (or joint net worth with his or her spouse) presently exceeds $1,000,000.
	 	 
	 	In
    calculating net worth, (a) the Investor’s or his or her spouse’s primary residence shall not be included as an
    asset, (b) indebtedness that is secured by such person’s primary residence, up to the estimated fair market value of
    the primary residence at the time of the sale of Preferred Stock, shall not be included as a liability (except that if the
    amount of such indebtedness outstanding at the time of the sale of the Preferred Stock exceeds the amount outstanding 60 days
    before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included
    as a liability), and (c) indebtedness that is secured by such person’s primary residence in excess of the estimated
    fair market value of the primary residence at the time of the sale of the Preferred Stock shall be included as a liability.
	 	 
	Category
    B  ___	The
    Investor is (a) an individual (not a partnership, corporation, etc.) who had an income in excess of $200,000 in each of the
    two most recent years, or joint income with his or her spouse in excess of $300,000 in each of those years (in each case including
    foreign income, tax exempt income and full amount of capital gains and losses but excluding any income of other family members
    and any unrealized capital appreciation) and has a reasonable expectation of reaching the same income level in the current
    year or (b) a Retirement Account and the Retirement Account participant meets the tests in clause (a).

 

    	10

    	 

    

 

	Category
    C  ___	The
    Investor is a director or executive officer of the Company which is issuing and selling the Shares.
	 	 
	Category
    D  ___	The
    Investor is a bank; a savings and loan association; insurance Company; registered investment Company; registered business
    development Company; licensed small business investment Company (“SBIC”); or employee benefit plan within the
    meaning of Title 1 of ERISA and (a) the investment decision is made by a plan fiduciary which is either a bank, savings and
    loan association, insurance Company or registered investment advisor, or (b) the plan has total assets in excess of $5,000,000
    or (c) is a self directed plan with investment decisions made solely by persons that are accredited investors. (describe entity)
	 	 
	 	______________________________________________________
	 	______________________________________________________
	 	 
	Category
    E  ___	The
    Investor is a private business development Company as defined in section 202(a)(22) of the Investment Advisors Act of 1940.
    (describe entity) 
	 	 
	 	______________________________________________________
		______________________________________________________
	 	 
	Category
    F  ___	The
    Investor is either a corporation, partnership, Massachusetts business trust, or non-profit organization within the meaning
    of Section 501(c)(3) of the Internal Revenue Code, in each case not formed for the specific purpose of acquiring the Shares
    and with total assets in excess of $5,000,000. (describe entity)
	 	 
	 	______________________________________________________
	 	______________________________________________________
	 	 
	Category
    G  ___	The
    Investor is a trust with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Shares,
    where the purchase is directed by a “sophisticated investor” as defined in Regulation 506(b)(2)(ii) under the
    Act.
	 	 
	Category
    H  ___	The
    Investor is a revocable trust and the grantor is an accredited investor pursuant to the following category: _____________________
	 	 
	Category
    I  ___	The
    Investor is an entity (other than a trust) in which all of the equity owners are “accredited investors” within
    one or more of the above categories. If relying upon this Category alone, each equity owner must complete a separate copy
    of this Agreement. (describe entity)
	 	 
	 	______________________________________________________
		______________________________________________________
	 	 
	Category
    J  ___	The
    Investor is not within any of the categories above and is therefore not an accredited investor.
	 	 
	 	The
    Investor agrees that the undersigned will notify the Company at any time on or prior to the closing in the event that the
    representations and warranties in this Agreement shall cease to be true, accurate and complete.

 

    	11

    	 

    

 

The
Investor is informed of the significance to the Company of the foregoing representations and answers contained in the Confidential
Investor Questionnaire contained in this Article and such answers have been provided under the assumption that the Company will
rely on them.

 

**
SIGNATURES FOLLOW **

 

The
Investor has set their hand on the date above.

 

_______________________________________

 

INVESTOR

 

ACKNOWLEDGEMENT
OF SUBMISSION

OF
PRINCIPLE AMOUNT BY FOMO

 

This
Stock Purchase Agreement is agreed to and

accepted
as of ________________, 2021.

 

________________________________

[
Signature] 

Vikram
Grover

CEO

 

    	12

    	 

    

 

CERTIFICATE
OF SIGNATORY

 

(To
be completed if the Preferred Stock

being
subscribed for by an entity)

 

I,_________________________________,
am the ______________________________ of

 

_________________________________________
(the “Entity”).

 

I
certify that I am empowered and duly authorized by the Entity to execute and carry out the terms of the Stock Purchase Agreement
and to purchase and hold the Preferred Stock, and certify further that the Stock Purchase Agreement has been duly and validly
executed on behalf of the Entity and constitutes a legal and binding obligation of the Entity.

 

IN
WITNESS WHEREOF, I have set my hand this ________ day of _________________, 2021

 

	 	 _______________________________________
	 	 (Signature)

 

    	13Exhibit
10.3

 

NEITHER
THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A
LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN
ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

FOMO
CORP. p/k/a 2050 Motors, Inc.

 

Warrant
Shares: 12,500,000

Date
of Issuance: February 10, 2021 (“Issuance Date”)

 

This
COMMON STOCK PURCHASE WARRANT (WARRANT A) (the “Warrant”) certifies that, for value received (in connection
with the purchase of up to $25,000.00 Series A Convertible Preferred Shares by the Holder (as defined below) of even date) (the
“Note”), ____________________, a _________________ (including any permitted and registered assigns, the “Holder”),
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the issuance hereof, to purchase from FOMO CORP., a California corporation which was previously known as 2050 Motors,
Inc (the “Company”), up to ___________ shares of Common Stock (as defined below) (the “Warrant Shares”)
(whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price
per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities
purchase agreement dated February 10, 2021, by and among the Company and the Holder (the “Purchase Agreement”).

 

Capitalized
terms used in this Warrant shall have the meanings set forth in the Purchase Agreement unless otherwise defined in the body of
this Warrant or in Section 12 below. For purposes of this Warrant, the term “Exercise Price” shall mean $0.003,
subject to adjustment as provided herein (including but not limited to cashless exercise), and the term “Exercise Period”
shall mean the period commencing at any time on or after the date hereof and ending on 5:00 p.m. eastern standard time on the
five-year anniversary thereof.

 

1.
EXERCISE OF WARRANT.

 

(a)
Mechanics of Exercise. Subject to the terms and conditions hereof, the rights represented by this Warrant may be exercised
in whole or in part at any time or times during the Exercise Period by delivery of a written notice, in the form attached hereto
as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Warrant. The Holder
shall not be required to deliver the original Warrant in order to effect an exercise hereunder. Partial exercises of this Warrant
resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering
the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.
On or before the second Trading Day (the “Warrant Share Delivery Date”) following the date on which the Holder
sent the Exercise Notice to the Company or the Company’s transfer agent, and upon receipt by the Company of payment to the
Company of an amount equal to the applicable Exercise Price multiplied by the number of Warrant Shares as to which all or a portion
of this Warrant is being exercised (the “Aggregate Exercise Price” and together with the Exercise Notice, the
“Exercise Delivery Documents”) in cash or by wire transfer of immediately available funds (or by cashless exercise,
in which case there shall be no Aggregate Exercise Price provided), the Company shall (or direct its transfer agent to) issue
and dispatch by overnight courier to the address as specified in the Exercise Notice, a certificate, registered in the Company’s
share register in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled
pursuant to such exercise (or deliver such shares of Common Stock in electronic format if requested by the Holder). Upon delivery
of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the certificates
evidencing such Warrant Shares. If this Warrant is submitted in connection with any exercise and the number of Warrant Shares
represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise,
then the Company shall as soon as practicable and in no event later than three Business Days after any exercise and at its own
expense, issue a new Warrant (in accordance with Section 6) representing the right to purchase the number of Warrant Shares purchasable
immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is
exercised.

 

    	 

    	 

    

 

If
the Company fails to cause its transfer agent to transmit to the Holder the respective shares of Common Stock by the respective
Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise in Holder’s sole discretion, and
such failure shall be deemed an event of default under the Note.

 

If
the Market Price of one share of Common Stock is greater than the Exercise Price and the full number of shares issuable
upon exercise of this warrant have NOT been registered pursuant to an S1 or S3 registration statement which has been declared
effective by the Securities and Exchange Commission, then the Holder may elect to receive Warrant Shares pursuant to a
cashless exercise, in lieu of a cash exercise, equal to the value of this Warrant determined in the manner described below (or
of any portion thereof remaining unexercised) by surrender of this Warrant and a Notice of Exercise, in which event the Company
shall issue to Holder a number of Common Stock computed using the following formula:

 

X
= Y (A-B)

A

 

	Where  	 X =	the number of Shares to be issued to Holder.

 

		Y
                                         =	the
                                         number of Warrant Shares that the Holder elects to purchase under this Warrant (at the
                                         date of such calculation).

 

	 	A =	 the Market
Price (at the date of such calculation).

 

	 	B =	 Exercise
Price (as adjusted to the date of such calculation).

 

(b)
No Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a consequence of any adjustment
pursuant hereto. All Warrant Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes
of determining whether the exercise would result in the issuance of any fractional share. If, after aggregation, the exercise
would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay the Holder
otherwise entitled to such fraction a sum in cash equal to the product resulting from multiplying the then-current fair market
value of a Warrant Share by such fraction.

 

    	2

    	 

    

 

(c)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, to the extent that after giving effect to issuance of Warrant Shares upon
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess
of the Beneficial Ownership Limitation, as defined below. For purposes of the foregoing sentence, the number of shares of Common
Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise
of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock
which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates and (ii) exercise or conversion of the unexercised or non-converted portion of any other securities of
the Company (including without limitation any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates. Except as set forth in
the preceding sentence, for purposes of this paragraph (d), beneficial ownership shall be calculated in accordance with Section
13(d) of the Exchange Act, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be
filed in accordance therewith. To the extent that the limitation contained in this paragraph applies, the determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates) and of which portion
of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial
Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.

 

For
purposes of this paragraph, in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the
Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the
Company or its transfer agent setting forth the number of shares of Common Stock outstanding. Upon the request of a Holder, the
Company shall within two Trading Days confirm to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its affiliates since the date as of which such number of outstanding
shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of
shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant.

 

2.
ADJUSTMENTS. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

 

(a)
Distribution of Assets. If the Company shall declare or make any dividend or other distribution of its assets (or rights
to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including without limitation
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate
rearrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant,
then, in each such case:

 

(i)
any Exercise Price in effect immediately prior to the close of business on the record date fixed for the determination of holders
of shares of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such
record date, to a price determined by multiplying such Exercise Price by a fraction (i) the numerator of which shall be the Closing
Sale Price of the shares of Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution
(as determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the
denominator of which shall be the Closing Sale Price of the shares of Common Stock on the Trading Day immediately preceding such
record date; and

 

(ii)
the number of Warrant Shares shall be increased to a number of shares equal to the number of shares of Common Stock obtainable
immediately prior to the close of business on the record date fixed for the determination of holders of shares of Common Stock
entitled to receive the Distribution multiplied by the reciprocal of the fraction set forth in the immediately preceding clause
(i); provided, however, that in the event that the Distribution is of shares of common stock of a company (other than the Company)
whose common stock is traded on a national securities exchange or a national automated quotation system (“Other Shares
of Common Stock”), then the Holder may elect to receive a warrant to purchase Other Shares of Common Stock in lieu of
an increase in the number of Warrant Shares, the terms of which shall be identical to those of this Warrant, except that such
warrant shall be exercisable into the number of shares of Other Shares of Common Stock that would have been payable to the Holder
pursuant to the Distribution had the Holder exercised this Warrant immediately prior to such record date and with an aggregate
exercise price equal to the product of the amount by which the exercise price of this Warrant was decreased with respect to the
Distribution pursuant to the terms of the immediately preceding clause (i) and the number of Warrant Shares calculated in accordance
with the first part of this clause (ii).

 

    	3

    	 

    

 

(b)
Anti-Dilution Adjustments to Exercise Price. If the Company or any Subsidiary thereof, as applicable, at any time while
this Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose
of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or securities
entitling any person or entity to acquire shares of Common Stock (upon conversion, exercise or otherwise) (including but not limited
to under the Note), at an effective price per share less than the then Exercise Price (such lower price, the “Base Share
Price” and such issuances collectively, a “Dilutive Issuance”) (if the holder of the Common Stock
or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, elimination of an
applicable floor price for any reason in the future (including but not limited to the passage of time or satisfaction of certain
condition(s)), reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or
rights per share which are issued in connection with such issuance, be entitled or potentially entitled to receive shares of Common
Stock at an effective price per share which is less than the Exercise Price at any time while such Common Stock or Common Stock
Equivalents are in existence, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of
the Dilutive Issuance (regardless of whether the Common Stock, Common Stock Equivalents, or Note are (i) subsequently redeemed
or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted or exercised at such Base Share Price),
then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal the Base Share Price, and the number
of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable hereunder, after taking
into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price prior to such adjustment (for
the avoidance of doubt, the aggregate Exercise Price prior to such adjustment is calculated as follows: the total number of Warrant
Shares issuable upon exercise of this Warrant immediately prior to such adjustment (without regard to the Beneficial Ownership
Limitation) multiplied by the Exercise Price in effect immediately prior to such adjustment). By way of example, if E is the total
number of Warrant Shares issuable upon exercise of this Warrant immediately prior to such adjustment (without regard to the Beneficial
Ownership Limitation), F is the Exercise Price in effect immediately prior to such adjustment, and G is the Base Share Price,
the adjustment to the number of Warrant Shares can be expressed in the following formula: Total number of Warrant Shares after
such Dilutive Issuance = the number obtained from dividing [E x F] by G. Such adjustment shall be made whenever such Common Stock
or Common Stock Equivalents are issued, regardless of whether the Common Stock, Common Stock Equivalents, or Note are (i) subsequently
redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted or exercised at such Base
Share Price by the holder thereof (for the avoidance of doubt, the Holder may utilize the Base Share Price even if the Company
did not actually issue shares of its common stock at the Base Share Price under the respective Common stock Equivalents or Note).
The Company shall notify the Holder in writing, no later than the Trading Day following the issuance of any Common Stock or Common
Stock Equivalents subject to this Section 2(b), indicating therein the applicable issuance price, or applicable reset price, exchange
price, conversion price and other pricing terms (such notice the “Dilutive Issuance Notice”). For purposes
of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 2(b), upon the occurrence
of any Dilutive Issuance, after the date of such Dilutive Issuance the Holder is entitled to receive a number of Warrant Shares
based upon the Base Share Price regardless of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise.

 

    	4

    	 

    

 

(c)
Subdivision or Combination of Common Stock. If the Company at any time on or after the Issuance Date subdivides (by any
stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into
a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced
and the number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Issuance Date combines
(by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller
number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the
number of Warrant Shares will be proportionately decreased. Any adjustment under this Section 2(c) shall become effective at the
close of business on the date the subdivision or combination becomes effective. Each such adjustment of the Exercise Price shall
be calculated to the nearest one-hundredth of a cent. Such adjustment shall be made successively whenever any event covered by
this Section 2(c) shall occur.

 

3.
FUNDAMENTAL TRANSACTIONS. If, at any time while this Warrant is outstanding, (i) the Company effects any merger of the
Company with or into another entity and the Company is not the surviving entity (such surviving entity, the “Successor
Entity”), (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related
transactions, (iii) any tender offer or exchange offer (whether by the Company or by another individual or entity, and approved
by the Company) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common
Stock for other securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iv) the
Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination
of shares of Common Stock) (in any such case, a “Fundamental Transaction”), then, upon any subsequent exercise
of this Warrant, the Holder shall have the right to receive the number of shares of Common Stock of the Successor Entity or of
the Company and any additional consideration (the “Alternate Consideration”) receivable upon or as a result
of such reorganization, reclassification, merger, consolidation or disposition of assets by a holder of the number of shares of
Common Stock for which this Warrant is exercisable immediately prior to such event (disregarding any limitation on exercise contained
herein solely for the purpose of such determination). For purposes of any such exercise, the determination of the Exercise Price
shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable
in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among
the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate
Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of
this Warrant following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any Successor
Entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing
the Holder’s right to exercise such warrant into Alternate Consideration.

 

4.
NON-CIRCUMVENTION. The Company covenants and agrees that it will not, by amendment of its certificate of incorporation,
bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or
sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of
this Warrant, and will at all times in good faith carry out all the provisions of this Warrant and take all action as may be required
to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (i) shall not increase the
par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect,
(ii) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and non-assessable shares of Common Stock upon the exercise of this Warrant, and (iii) shall, for so long as this Warrant
is outstanding, have authorized and reserved, free from preemptive rights, ten times the number of shares of Common Stock that
is actually issuable upon full exercise of the Warrant (based on the Exercise Price in effect from time to time, and without regard
to any limitations on exercise).

 

5.
WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, this Warrant, in and of itself,
shall not entitle the Holder to any voting rights or other rights as a stockholder of the Company. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this
Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors
of the Company.

 

    	5

    	 

    

 

6.
REISSUANCE.

 

(a)
Lost, Stolen or Mutilated Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms
as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender
thereof), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or destroyed.

 

(b)
Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant,
such new Warrant shall be of like tenor with this Warrant, and shall have an issuance date, as indicated on the face of such new
Warrant which is the same as the Issuance Date.

 

7.
TRANSFER. This Warrant shall be binding upon the Company and its successors and assigns, and shall inure to be the benefit
of the Holder and its successors and assigns. Notwithstanding anything to the contrary herein, the rights, interests or obligations
of the Company hereunder may not be assigned, by operation of law or otherwise, in whole or in part, by the Company without the
prior signed written consent of the Holder, which consent may be withheld at the sole discretion of the Holder (any such assignment
or transfer shall be null and void if the Company does not obtain the prior signed written consent of the Holder). This Warrant
or any of the severable rights and obligations inuring to the benefit of or to be performed by Holder hereunder may be assigned
by Holder to a third party, in whole or in part, without the need to obtain the Company’s consent thereto.

 

8.
NOTICES. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall
be given in accordance with the notice provisions contained in the Purchase Agreement. The Company shall provide the Holder with
prompt written notice (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, the calculation
of such adjustment and (ii) at least 20 days prior to the date on which the Company closes its books or takes a record (A) with
respect to any dividend or distribution upon the shares of Common Stock, (B) with respect to any grants, issuances or sales of
any stock or other securities directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock
or other property, pro rata to the holders of shares of Common Stock or (C) for determining rights to vote with respect to any
Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall be made known to the public
prior to or in conjunction with such notice being provided to the Holder.

 

9.
AMENDMENT AND WAIVER. The terms of this Warrant may be amended or waived (either generally or in a particular instance
and either retroactively or prospectively) only with the written consent of the Company and the Holder.

 

10.
GOVERNING LAW AND VENUE. This Warrant shall be governed by and construed in accordance with the laws of the State of California
without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Warrant shall be brought only in the state courts located in the State of Illinois or in the federal courts
located in the State of Illinois. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue
of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum
non conveniens. THE ISSUER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL
FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED
HEREBY. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs.
In the event that any provision of this Warrant or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party
hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in
connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

    	6

    	 

    

 

11.
ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and
conditions contained herein.

 

12.
CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

 

(a)
“Nasdaq” means www.Nasdaq.com.

 

(b)
“Closing Sale Price” means, for any security as of any date, (i) the last closing trade price for such security
on the Principal Market, as reported by Nasdaq, or, if the Principal Market begins to operate on an extended hours basis and does
not designate the closing trade price, then the last trade price of such security prior to 4:00 p.m., New York time, as reported
by Nasdaq, or (ii) if the foregoing does not apply, the last trade price of such security in the over-the-counter market for such
security as reported by Nasdaq, or (iii) if no last trade price is reported for such security by Nasdaq, the average of the bid
and ask prices of any market makers for such security as reported by the OTC Markets. If the Closing Sale Price cannot be calculated
for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall
be the fair market value as mutually determined by the Company and the Holder. All such determinations to be appropriately adjusted
for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

 

(c)
“Common Stock” means the Company’s common stock, and any other class of securities into which such securities
may hereafter be reclassified or changed.

 

(d)
“Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire
at any time Common Stock, including without limitation any debt, preferred stock, rights, options, warrants or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock.

 

(e)
“Dilutive Issuance” is any issuance of Common Stock or Common Stock Equivalents described in Section 2(b) above;
provided, however, that a Dilutive Issuance shall not include any Exempt Issuance.

 

(f)
“Exempt Issuance” means the issuance of (i) shares of Common Stock or options to employees, officers, or directors
of the Company pursuant to any stock or option plan duly adopted by a majority of the non-employee members of the Board of Directors
of the Company or a majority of the members of a committee of non-employee directors established for such purpose, and (ii) shares
of Common Stock issued pursuant to real property leasing arrangement from a bank approved by the Board of Directors of the Company.

 

(g)
“Principal Market” means the primary national securities exchange on which the Common Stock is then traded.

 

(h)
“Market Price” means the average of the previous VWAP for the 5 trading days immediately prior to the date
of the respective Exercise Notice.

 

(i)
“Trading Day” means (i) any day on which the Common Stock is listed or quoted and traded on its Principal Market,
(ii) if the Common Stock is not then listed or quoted and traded on any national securities exchange, then a day on which trading
occurs on any over-the-counter markets, or (iii) if trading does not occur on the over-the-counter markets, any Business Day.

 

*
* * * * * *

 

    	7

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Issuance Date set forth above.

 

	 	FOMO
    CORP
	 	 	 
	 	 
	 	Name: 	Vikram Grover
	 	Title:	Chief Executive
    Officer

 

    	 

    	 

    

 

EXHIBIT
A

 

EXERCISE
NOTICE

 

(To
be executed by the registered holder to exercise this Common Stock Purchase Warrant)

 

The
Undersigned holder hereby exercises the right
to purchase _________________ of the shares of Common Stock (“Warrant Shares”) of FOMO CORP., a California corporation
p/k/a 2050 Motors, Inc (the “Company”), evidenced by the attached copy of the Common Stock Purchase Warrant (the “Warrant”).
Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

	1.	Form
                                         of Exercise Price. The Holder intends that payment of the Exercise Price shall be
                                         made as (check one):

 

[  ]
a cash exercise with respect to _________________ Warrant Shares; or

[  ]
by cashless exercise pursuant to the Warrant.

 

	2.	Payment
                                         of Exercise Price. If cash exercise is selected above, the holder shall pay the applicable
                                         Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
                                         with the terms of the Warrant.

 

	3.	Delivery
                                         of Warrant Shares. The Company shall deliver to the holder __________________ Warrant
                                         Shares in accordance with the terms of the Warrant.

 

Date:
________________________

 

	 	 
	 	(Print
    Name of Registered Holder)
	 	 	 
	 	By:	      
	 	Name:	 
	 	Title:	 

 

    	 

    	 

    

 

EXHIBIT
B

 

ASSIGNMENT
OF WARRANT

 

(To
be signed only upon authorized transfer of the Warrant)

 

For
Value Received, the undersigned hereby sells,
assigns, and transfers unto ____________________ the right to purchase _______________ shares of common stock of FOMO CORP., to
which the within Common Stock Purchase Warrant relates and appoints ____________________, as attorney-in-fact, to transfer said
right on the books of FOMO CORP. with full power of substitution and re-substitution in the premises. By accepting such transfer,
the transferee has agreed to be bound in all respects by the terms and conditions of the within Warrant.

 

Dated:
________________________

 

	 	 
	 	(Signature)
    *
	 	 
	 	 
	 	(Name)
	 	 
	 	 
	 	(Address)
	 	 
	 	 
	 	(Social
    Security or Tax Identification No.)

 

*
The signature on this Assignment of Warrant must correspond to the name as written upon the face of the Common Stock Purchase
Warrant in every particular without alteration or enlargement or any change whatsoever. When signing on behalf of a corporation,
partnership, trust or other entity, please indicate your position(s) and title(s) with such entity.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]